Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Sep 08, 2026
ProShares Ultra Ether ETF (ETHT) Delivers +58% Gain Over 30 Days as Ether Advances

ProShares Ultra Ether ETF (ETHT) Delivers +58% Gain Over 30 Days as Ether Advances

Key Takeaways

  • ETHT, a 2x daily leveraged Ether (Ethereum) fund, rose roughly 58% over the last 30 days, tracking one of Ether's sharpest rallies of the year.
  • Over the trailing quarter, ETHT gained about 66%, though the path was exceptionally volatile, with a 52-week low near $7 in late June preceding the rebound.
  • The surge was driven by a U.S. Treasury long-dated bond buyback announcement, a proposed SEC crypto framework, and a sizable short squeeze.
  • Spot Ether ETF inflows reached their largest single-day total since late 2025, reinforcing institutional demand.
  • As a daily-reset leveraged product, ETHT's returns can diverge substantially from Ether's over longer holding periods due to compounding effects.

ProShares Ultra Ether ETF (ETHT) Structure and Exposure

The ProShares Ultra Ether ETF (ETHT) is a leveraged exchange-traded fund that seeks daily investment results, before fees and expenses, corresponding to two times (2x) the daily performance of the Bloomberg Ethereum Index. Launched in June 2024, the fund does not invest directly in Ether; instead, it gains exposure through financial instruments such as swap agreements, futures contracts, and similar derivatives.

Unlike a broad equity or sector ETF, ETHT holds no company stocks. Its portfolio consists of a small number of positions—fewer than a dozen—dominated by an Ether-linked total-return swap, U.S. Treasury and cash collateral, and futures contracts. The fund has a net expense ratio of approximately 0.94% and roughly $180 million in assets under management (AUM).

This structure explains the fund's recent behavior: because it targets 2x daily exposure and resets leverage each session, ETHT amplifies Ether's day-to-day moves, including the sharp rally that unfolded in mid-August. I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the sector.

ProShares Ultra Ether ETF (ETHT) Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, ETHT climbed from approximately $10.60 to $16.72, a gain of roughly +58%. The move was abrupt rather than gradual, concentrated in a single burst around mid-August when the fund jumped from about $10.48 to $12.57 in one session and continued higher in the following days.

Over the trailing quarter, the picture is more complex. The fund advanced about +66% from roughly $10.05 in early June to $16.72. However, this headline gain masks a deep drawdown: ETHT fell to a 52-week low near $7 in late June before staging a sharp, V-shaped recovery. Despite the recent strength, the fund remains well below its 52-week high of about $131.74.

What Drove ETHT Price in the Last 30 Days

The primary driver was a surge in Ether, which ETHT magnifies through leverage. Ether rose from below $1,950 to above $2,250, reaching a 15-month high, after several catalysts converged.

First, the U.S. Treasury announced it would double the maximum size of liquidity-support buybacks for longer-dated government debt to at least $4 billion per operation, effective in early September. The news pushed long-end Treasury yields lower, weakened the dollar, and lifted risk appetite across digital assets.

Second, the Securities and Exchange Commission (SEC) proposed a new regulatory framework for crypto token offerings, which markets interpreted as a constructive step toward clearer rules. A White House meeting with crypto executives, including COIN (Coinbase) and HOOD (Robinhood), and a renewed push for the CLARITY Act reinforced the regulatory tailwind.

Third, the breakout triggered a major short squeeze. More than $1 billion in Ether-linked short positions were liquidated, forcing bearish traders to buy back into a rising market and accelerating the rally. Spot Ether ETFs also absorbed record inflows, including roughly $189 million in a single session—the largest daily total since late 2025.

What Drove ETHT Performance Over the Last Quarter

The trailing quarter reflects two distinct phases. From May into late June, Ether and ETHT fell sharply as risk sentiment deteriorated and Ether repeatedly failed to hold the $2,000 level. ETHT bottomed near $7 in late June as leveraged selling and negative momentum compounded the decline.

The second phase began in August, when improving macro liquidity, a more favorable regulatory outlook, and a rotation into higher-beta assets sparked a recovery. The ETH/BTC ratio climbed, indicating investors were reallocating specifically toward Ether rather than merely following Bitcoin. Institutional ETF flows turned positive and accelerated, supporting the rebound. Because ETHT provides 2x daily leverage, it amplified both the earlier drawdown and the subsequent recovery.

ETHT ETF Outlook: What Investors Should Watch Next

Several factors are likely to shape ETHT over the coming months. The Treasury buyback program is scheduled to run through early November, keeping the macro liquidity backdrop supportive while it remains active. The SEC's proposed crypto framework is still in a public comment period, and final rules could take months to formalize; progress or setbacks on the CLARITY Act will also influence sentiment.

Ether's technical position remains relevant, as the asset sits in overbought territory after a rapid advance. Sustained spot Ether ETF inflows, continued growth in staking, tokenization, and stablecoin activity on the Ethereum network, and broader interest-rate expectations will all matter. Investors should also weigh the structural risks of daily-reset leverage, including volatility decay, which can erode returns in choppy or range-bound markets even when the underlying asset is flat or modestly higher.

Using Tickeron’s AI Screener for ETF Analysis

In my research on leveraged products like ETHT, I often turn to Tickeron’s AI Screener to quickly filter for momentum shifts and compare volatility across similar funds. It helps surface technical patterns and performance data without manually reviewing dozens of charts, which keeps the process more efficient when evaluating sector exposure and recent moves.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ETHT

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


ETHT in +26.37% Uptrend, advancing for three consecutive days on September 21, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ETHT advanced for three days, in 95 of 107 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Aroon Indicator entered an Uptrend today. In 65 of 74 cases where ETHT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 88%.

Bearish Trend Analysis

The 10-day RSI Indicator for ETHT moved out of overbought territory on September 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 10 similar instances where the indicator moved out of overbought territory. In 9 of the 10 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 20 of 21 cases where ETHT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.

The Momentum Indicator moved below the 0 level on October 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ETHT as a result. In 42 of 45 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for ETHT turned negative on September 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 17 similar instances when the indicator turned negative. In 14 of the 17 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ETHT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

ETHT broke above its upper Bollinger Band on September 18, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Industry description

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Bloomberg Ethereum Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. In this manner, the fund seeks daily returns that correspond to two times (2x) the price of ether. The fund does not invest directly in ether.
View a ticker or compare two or three
ETHT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Trading

Category
Trading--Miscellaneous
Address
ProShares Trust7501 Wisconsin Avenue,Suite 1000Bethesda
Phone
N/A
Web
www.proshares.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
GE Aerospace (GE) stock declined -12% over the past 30 days, falling from around $333 to $293, amid profit-taking after record highs near $348. Over the past quarter, the stock is down -8%, reflecting post-earnings selloff despite strong Q4 2025 results with 20% revenue growth.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
NBR stock rose approximately +12% over the last 30 days, driven by positive momentum in the oil and gas drilling sector and strong Q4 earnings beat. Over the past quarter, the stock surged +58%, fueled by robust YTD performance, debt reduction efforts, and improved operational results in international drilling.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.